JMNCX Performance — JPMorgan Research Market Neutral Fund, Class C
Data updated: 2026-09-28
JMNCX returned −3.45% year to date and −4.12% over one year to Jul 2026. Annualised returns are +5.08% over 3 years and +4.26% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $116, against $153 for the category, and to $96 over one year, against $116. Volatility over the past three years was 3.88% a year. In the 12 months to Jul 2026 the fund took in a net $12.9M, and assets reached $367.88M.
JMNCX Growth of $100
What $100 invested in JPMorgan Research Market Neutral Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | JMNCX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $96 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $116 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $123 | $159 |
| Since data start (Aug 2019 – Jul 2026) | $137 | $226 |
JMNCX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −3.45% |
| 1 year | −4.12% |
| 3 years (annualised) | +5.08% |
| 5 years (annualised) | +4.26% |
JMNCX Annual Returns
Calendar-year total returns of JPMorgan Research Market Neutral Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −3.45% |
| 2025 | +2.90% |
| 2024 | +11.54% |
| 2023 | +10.45% |
| 2022 | −2.76% |
| 2021 | +3.22% |
| 2020 | +11.45% |
| 2019 (Aug–Dec) | −0.29% |
JMNCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.6% | −1.8% | +0.2% | +0.9% | −1.5% | +1.9% | −1.5% | — | — | — | — | — |
| 2025 | +0.4% | 0.0% | −1.6% | +1.3% | +1.3% | +1.2% | +1.1% | −0.5% | −0.4% | −0.2% | −0.2% | +0.6% |
| 2024 | +1.2% | +1.8% | +0.9% | +1.6% | +0.8% | +0.9% | −1.2% | +0.9% | +0.4% | +2.6% | +1.3% | −0.2% |
| 2023 | +0.2% | +1.1% | +0.9% | +1.2% | +2.1% | +0.3% | −0.3% | +1.2% | +0.7% | +0.3% | +2.0% | +0.4% |
| 2022 | −2.0% | +0.6% | −1.8% | −1.0% | −1.8% | +0.2% | +1.8% | 0.0% | +1.1% | −1.5% | +0.9% | +0.7% |
| 2021 | −3.2% | +1.5% | +1.1% | +1.8% | −1.3% | −1.6% | +1.5% | −0.9% | +0.9% | +2.2% | +0.8% | +0.4% |
| 2020 | +3.5% | +1.8% | +2.4% | +0.3% | +0.7% | −0.8% | +1.4% | +1.1% | +0.5% | −0.3% | −0.4% | +0.8% |
| 2019 | — | — | — | — | — | — | — | +2.3% | −3.5% | +0.7% | +0.1% | +0.2% |
JMNCX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 3.88%
- 3-year Sharpe ratio: 0.15 (vs 4.5% risk-free rate)
- Best month: +2.56% (Oct 2024)
- Worst month: −1.75% (Feb 2026)
JMNCX Fund Flows
Monthly money in and out of JPMorgan Research Market Neutral Fund, from SEC Form N-PORT.
- 12-month net flow: $12.9M
- 12-month gross sales (incl. reinvestments): $247.4M
- Sales ÷ redemptions: 1.06×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $52.0M | $10.1M | $42.0M |
| Jun 2026 | $5.7M | $11.5M | −$5.7M |
| May 2026 | $21.8M | $19.3M | $2.5M |
| Apr 2026 | $8.3M | $18.2M | −$9.9M |
| Mar 2026 | $8.7M | $14.5M | −$5.8M |
| Feb 2026 | $11.9M | $22.5M | −$10.6M |
| Jan 2026 | $10.0M | $19.4M | −$9.4M |
| Dec 2025 | $28.4M | $30.3M | −$1.9M |
| Nov 2025 | $10.7M | $13.1M | −$2.4M |
| Oct 2025 | $19.1M | $30.7M | −$11.6M |
| Sep 2025 | $20.2M | $36.8M | −$16.6M |
| Aug 2025 | $50.6M | $8.1M | $42.4M |
JMNCX Assets Under Management
Net assets of JPMorgan Research Market Neutral Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $367.88M |
| 2026-04-30 | $332.71M |
| 2026-01-31 | $360.79M |
| 2025-10-31 | $389.29M |
| 2025-07-31 | $378.56M |
| 2025-04-30 | $340.68M |
| 2025-01-31 | $421.03M |
| 2024-10-31 | $339.22M |
| 2024-07-31 | $271.94M |
| 2024-04-30 | $253.31M |
| 2024-01-31 | $240.55M |
| 2023-10-31 | $221.77M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.